Structure of the toxic core of α-synuclein from invisible crystals
10.1038/nature15368
Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Rodriguez, J. A., Ivanova, M. I., Sawaya, M. R., Cascio, D., Reyes, F. E., Shi, D., Sangwan, S., Guenther, E. L., Johnson, L. M., Zhang, M., Jiang, L., Arbing, M. A., Nannenga, B. L., Hattne, J., Whitelegge, J., Brewster, A. S., Messerschmidt, M., Boutet, S., Sauter, N. K., … Eisenberg, D. S. (2015). Structure of the toxic core of α-synuclein from invisible crystals. Nature, 525(7570), 486–490.

Authors 21
  1. Jose A. Rodriguez (first)
  2. Magdalena I. Ivanova (additional)
  3. Michael R. Sawaya (additional)
  4. Duilio Cascio (additional)
  5. Francis E. Reyes (additional)
  6. Dan Shi (additional)
  7. Smriti Sangwan (additional)
  8. Elizabeth L. Guenther (additional)
  9. Lisa M. Johnson (additional)
  10. Meng Zhang (additional)
  11. Lin Jiang (additional)
  12. Mark A. Arbing (additional)
  13. Brent L. Nannenga (additional)
  14. Johan Hattne (additional)
  15. Julian Whitelegge (additional)
  16. Aaron S. Brewster (additional)
  17. Marc Messerschmidt (additional)
  18. Sébastien Boutet (additional)
  19. Nicholas K. Sauter (additional)
  20. Tamir Gonen (additional)
  21. David S. Eisenberg (additional)
References 61 Referenced 570
  1. Spillantini, M. G. et al. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997) (10.1038/42166) / Nature by MG Spillantini (1997)
  2. Goedert, M., Spillantini, M. G., Del Tredici, K. & Braak, H. 100 years of Lewy pathology. Nature Rev. Neurol. 9, 13–24 (2013) (10.1038/nrneurol.2012.242) / Nature Rev. Neurol. by M Goedert (2013)
  3. Polymeropoulos, M. H. et al. Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045–2047 (1997) (10.1126/science.276.5321.2045) / Science by MH Polymeropoulos (1997)
  4. Krüger, R. et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nature Genet. 18, 106–108 (1998) (10.1038/ng0298-106) / Nature Genet. by R Krüger (1998)
  5. Zarranz, J. J. et al. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164–173 (2004) (10.1002/ana.10795) / Ann. Neurol. by JJ Zarranz (2004)
  6. Ibáñez, P. et al. Causal relation between α-synuclein gene duplication and familial Parkinson’s disease. Lancet 364, 1169–1171 (2004) (10.1016/S0140-6736(04)17104-3) / Lancet by P Ibáñez (2004)
  7. Singleton, A. B. et al. α-Synuclein locus triplication causes Parkinson’s disease. Science 302, 841 (2003) (10.1126/science.1090278) / Science by AB Singleton (2003)
  8. Uéda, K. et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 11282–11286 (1993) (10.1073/pnas.90.23.11282) / Proc. Natl Acad. Sci. USA by K Uéda (1993)
  9. Biere, A. L. et al. Parkinson’s disease-associated α-synuclein is more fibrillogenic than β- and γ-synuclein and cannot cross-seed its homologs. J. Biol. Chem. 275, 34574–34579 (2000) (10.1074/jbc.M005514200) / J. Biol. Chem. by AL Biere (2000)
  10. Giasson, B. I., Murray, I. V. J., Trojanowski, J. Q. & Lee, V. M.-Y. A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly. J. Biol. Chem. 276, 2380–2386 (2001) (10.1074/jbc.M008919200) / J. Biol. Chem. by BI Giasson (2001)
  11. Du, H.-N. et al. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human α-synuclein. Biochemistry 42, 8870–8878 (2003) (10.1021/bi034028+) / Biochemistry by H-N Du (2003)
  12. Periquet, M., Fulga, T., Myllykangas, L., Schlossmacher, M. G. & Feany, M. B. Aggregated α-synuclein mediates dopaminergic neurotoxicity in vivo. J. Neurosci. 27, 3338–3346 (2007) (10.1523/JNEUROSCI.0285-07.2007) / J. Neurosci. by M Periquet (2007)
  13. Han, H., Weinreb, P. H. & Lansbury, P. T. The core Alzheimer’s peptide NAC forms amyloid fibrils, which seed and are seeded by β-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem. Biol. 2, 163–169 (1995) (10.1016/1074-5521(95)90071-3) / Chem. Biol. by H Han (1995)
  14. El-Agnaf, O. M. et al. Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments. FEBS Lett. 440, 71–75 (1998) (10.1016/S0014-5793(98)01418-5) / FEBS Lett. by OM El-Agnaf (1998)
  15. Crowther, R. A., Daniel, S. E. & Goedert, M. Characterisation of isolated α-synuclein filaments from substantia nigra of Parkinson’s disease brain. Neurosci. Lett. 292, 128–130 (2000) (10.1016/S0304-3940(00)01440-3) / Neurosci. Lett. by RA Crowther (2000)
  16. Der-Sarkissian, A., Jao, C. C., Chen, J. & Langen, R. Structural organization of α-synuclein fibrils studied by site-directed spin labeling. J. Biol. Chem. 278, 37530–37535 (2003) (10.1074/jbc.M305266200) / J. Biol. Chem. by A Der-Sarkissian (2003)
  17. Chen, M., Margittai, M., Chen, J. & Langen, R. Investigation of α-synuclein fibril structure by site-directed spin labeling. J. Biol. Chem. 282, 24970–24979 (2007) (10.1074/jbc.M700368200) / J. Biol. Chem. by M Chen (2007)
  18. Miake, H., Mizusawa, H., Iwatsubo, T. & Hasegawa, M. Biochemical characterization of the core structure of α-synuclein filaments. J. Biol. Chem. 277, 19213–19219 (2002) (10.1074/jbc.M110551200) / J. Biol. Chem. by H Miake (2002)
  19. Conway, K. A., Harper, J. D. & Lansbury, P. T. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nature Med. 4, 1318–1320 (1998) (10.1038/3311) / Nature Med. by KA Conway (1998)
  20. Polymeropoulos, M. H. et al. Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045–2047 (1997) (10.1126/science.276.5321.2045) / Science by MH Polymeropoulos (1997)
  21. Nelson, R. et al. Structure of the cross-β spine of amyloid-like fibrils. Nature 435, 773–778 (2005) (10.1038/nature03680) / Nature by R Nelson (2005)
  22. Sawaya, M. R. et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 447, 453–457 (2007) (10.1038/nature05695) / Nature by MR Sawaya (2007)
  23. Bodles, A. M., Guthrie, D. J., Greer, B. & Irvine, G. B. Identification of the region of non-Aβ component (NAC) of Alzheimer’s disease amyloid responsible for its aggregation and toxicity. J. Neurochem. 78, 384–395 (2001) (10.1046/j.1471-4159.2001.00408.x) / J. Neurochem. by AM Bodles (2001)
  24. Nannenga, B. L. & Gonen, T. Protein structure determination by MicroED. Curr. Opin. Struct. Biol. 27, 24–31 (2014) (10.1016/j.sbi.2014.03.004) / Curr. Opin. Struct. Biol. by BL Nannenga (2014)
  25. Nannenga, B. L., Shi, D., Leslie, A. G. W. & Gonen, T. High-resolution structure determination by continuous-rotation data collection in MicroED. Nature Methods 11, 927–930 (2014) (10.1038/nmeth.3043) / Nature Methods by BL Nannenga (2014)
  26. Shi, D., Nannenga, B. L., Iadanza, M. G. & Gonen, T. Three-dimensional electron crystallography of protein microcrystals. eLife 2, e01345 (2013) (10.7554/eLife.01345) / eLife by D Shi (2013)
  27. Nannenga, B. L., Shi, D., Hattne, J., Reyes, F. E. & Gonen, T. Structure of catalase determined by MicroED. eLife 3, e03600 (2014) (10.7554/eLife.03600) / eLife by BL Nannenga (2014)
  28. Yonekura, K., Kato, K., Ogasawara, M., Tomita, M. & Toyoshima, C. Electron crystallography of ultrathin 3D protein crystals: atomic model with charges. Proc. Natl Acad. Sci. USA 112, 3368–3373 (2015) (10.1073/pnas.1500724112) / Proc. Natl Acad. Sci. USA by K Yonekura (2015)
  29. Doyle, P. A. & Turner, P. S. Relativistic Hartree–Fock X-ray and electron scattering factors. Acta Crystallogr. A 24, 390–397 (1968) (10.1107/S0567739468000756) / Acta Crystallogr. A by PA Doyle (1968)
  30. Sarafian, T. A. et al. Impairment of mitochondria in adult mouse brain overexpressing predominantly full-length, N-terminally acetylated human α-synuclein. PLoS ONE 8, e63557 (2013) (10.1371/journal.pone.0063557) / PLoS ONE by TA Sarafian (2013)
  31. Caughey, B. & Lansbury, P. T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267–298 (2003) (10.1146/annurev.neuro.26.010302.081142) / Annu. Rev. Neurosci. by B Caughey (2003)
  32. Danzer, K. M., Schnack, C., Sutcliffe, A., Hengerer, B. & Gillardon, F. Functional protein kinase arrays reveal inhibition of p-21-activated kinase 4 by α-synuclein oligomers. J. Neurochem. 103, 2401–2407 (2007) (10.1111/j.1471-4159.2007.04933.x) / J. Neurochem. by KM Danzer (2007)
  33. Karpinar, D. P. et al. Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson’s disease models. EMBO J. 28, 3256–3268 (2009) (10.1038/emboj.2009.257) / EMBO J. by DP Karpinar (2009)
  34. Winner, B. et al. In vivo demonstration that α-synuclein oligomers are toxic. Proc. Natl Acad. Sci. USA 108, 4194–4199 (2011) (10.1073/pnas.1100976108) / Proc. Natl Acad. Sci. USA by B Winner (2011)
  35. Chen, S. W. et al. Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation. Proc. Natl Acad. Sci. USA 112, E1994–E2003 (2015) (10.1073/pnas.1421204112) / Proc. Natl Acad. Sci. USA by SW Chen (2015)
  36. Bousset, L. et al. Structural and functional characterization of two α-synuclein strains. Nature Commun. 4, 2575 (2013) (10.1038/ncomms3575) / Nature Commun. by L Bousset (2013)
  37. Auluck, P. K., Caraveo, G. & Lindquist, S. α-Synuclein: membrane interactions and toxicity in Parkinson’s disease. Annu. Rev. Cell Dev. Biol. 26, 211–233 (2010) (10.1146/annurev.cellbio.042308.113313) / Annu. Rev. Cell Dev. Biol. by PK Auluck (2010)
  38. Lee, J. C., Langen, R., Hummel, P. A., Gray, H. B. & Winkler, J. R. α-Synuclein structures from fluorescence energy-transfer kinetics: implications for the role of the protein in Parkinson’s disease. Proc. Natl Acad. Sci. USA 101, 16466–16471 (2004) (10.1073/pnas.0407307101) / Proc. Natl Acad. Sci. USA by JC Lee (2004)
  39. Sievers, S. A. et al. Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature 475, 96–100 (2011) (10.1038/nature10154) / Nature by SA Sievers (2011)
  40. Comellas, G. et al. Structured regions of α-synuclein fibrils include the early-onset Parkinson’s disease mutation sites. J. Mol. Biol. 411, 881–895 (2011) (10.1016/j.jmb.2011.06.026) / J. Mol. Biol. by G Comellas (2011)
  41. Vilar, M. et al. The fold of α-synuclein fibrils. Proc. Natl Acad. Sci. USA 105, 8637–8642 (2008) (10.1073/pnas.0712179105) / Proc. Natl Acad. Sci. USA by M Vilar (2008)
  42. Goldschmidt, L., Teng, P. K., Riek, R. & Eisenberg, D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc. Natl Acad. Sci. USA 107, 3487–3492 (2010) (10.1073/pnas.0915166107) / Proc. Natl Acad. Sci. USA by L Goldschmidt (2010)
  43. Otwinowski, Z. & Minor, W. in Methods in Enzymology (eds Carter, C. W. Jr & Sweet, R. M.) Vol. 276 307–326 (Academic Press, 1997) / Methods in Enzymology by Z Otwinowski (1997)
  44. Weierstall, U., Spence, J. C. H. & Doak, R. B. Injector for scattering measurements on fully solvated biospecies. Rev. Sci. Instrum. 83, 035108 (2012) (10.1063/1.3693040) / Rev. Sci. Instrum. by U Weierstall (2012)
  45. Hattne, J. et al. Accurate macromolecular structures using minimal measurements from X-ray free-electron lasers. Nature Methods 11, 545–548 (2014) (10.1038/nmeth.2887) / Nature Methods by J Hattne (2014)
  46. Sauter, N. K., Hattne, J., Grosse-Kunstleve, R. W. & Echols, N. New Python-based methods for data processing. Acta Crystallogr. D 69, 1274–1282 (2013) (10.1107/S0907444913000863) / Acta Crystallogr. D by NK Sauter (2013)
  47. Kabsch, W. XDS. Acta Crystallogr. D 66, 125–132 (2010) (10.1107/S0907444909047337) / Acta Crystallogr. D by W Kabsch (2010)
  48. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007) (10.1107/S0021889807021206) / J. Appl. Crystallogr. by AJ McCoy (2007)
  49. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240–255 (1997) (10.1107/S0907444996012255) / Acta Crystallogr. D by GN Murshudov (1997)
  50. Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D 68, 352–367 (2012) (10.1107/S0907444912001308) / Acta Crystallogr. D by PV Afonine (2012)
  51. Blanc, E. et al. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. Acta Crystallogr. D 60, 2210–2221 (2004) (10.1107/S0907444904016427) / Acta Crystallogr. D by E Blanc (2004)
  52. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010) (10.1107/S0907444910007493) / Acta Crystallogr. D by P Emsley (2010)
  53. Delano, W. The PyMOL Molecular Graphics System (Schrödinger LLC). http://www.pymol.org
  54. Jakes, R., Spillantini, M. G. & Goedert, M. Identification of two distinct synucleins from human brain. FEBS Lett. 345, 27–32 (1994) (10.1016/0014-5793(94)00395-5) / FEBS Lett. by R Jakes (1994)
  55. Johnson, M., Coulton, A. T., Geeves, M. A. & Mulvihill, D. P. Targeted amino-terminal acetylation of recombinant proteins in E. coli. PLoS ONE 5, e15801 (2010) (10.1371/journal.pone.0015801) / PLoS ONE by M Johnson (2010)
  56. Whitelegge, J. P., Zhang, H., Aguilera, R., Taylor, R. M. & Cramer, W. A. Full subunit coverage liquid chromatography electrospray ionization mass spectrometry (LCMS+) of an oligomeric membrane protein: cytochrome b 6 f complex from spinach and the cyanobacterium Mastigocladus laminosus. Mol. Cell. Proteomics MCP 1, 816–827 (2002) (10.1074/mcp.M200045-MCP200) / Mol. Cell. Proteomics MCP by JP Whitelegge (2002)
  57. Arvai, A. Adxv - A Program to Display X-ray Diffraction Images (2015) / Adxv - A Program to Display X-ray Diffraction Images by A Arvai (2015)
  58. Rao, J. N., Jao, C. C., Hegde, B. G., Langen, R. & Ulmer, T. S. A combinatorial NMR and EPR approach for evaluating the structural ensemble of partially folded proteins. J. Am. Chem. Soc. 132, 8657–8668 (2010) (10.1021/ja100646t) / J. Am. Chem. Soc. by JN Rao (2010)
  59. Brunger, A. T. Version 1.2 of the crystallography and NMR system. Nature Protocols 2, 2728–2733 (2007) (10.1038/nprot.2007.406) / Nature Protocols by AT Brunger (2007)
  60. Fabiola, F., Bertram, R., Korostelev, A. & Chapman, M. S. An improved hydrogen bond potential: impact on medium resolution protein structures. Protein Sci. 11, 1415–1423 (2002) (10.1110/ps.4890102) / Protein Sci. by F Fabiola (2002)
  61. Read, R. J. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallogr. A 42, 140–149 (1986) (10.1107/S0108767386099622) / Acta Crystallogr. A by RJ Read (1986)
Dates
Type When
Created 9 years, 11 months ago (Sept. 8, 2015, 10:35 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 1:45 p.m.)
Indexed 1 week, 1 day ago (Aug. 12, 2025, 6:01 p.m.)
Issued 9 years, 11 months ago (Sept. 1, 2015)
Published 9 years, 11 months ago (Sept. 1, 2015)
Published Online 9 years, 11 months ago (Sept. 9, 2015)
Published Print 9 years, 11 months ago (Sept. 1, 2015)
Funders 0

None

@article{Rodriguez_2015, title={Structure of the toxic core of α-synuclein from invisible crystals}, volume={525}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/nature15368}, DOI={10.1038/nature15368}, number={7570}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Rodriguez, Jose A. and Ivanova, Magdalena I. and Sawaya, Michael R. and Cascio, Duilio and Reyes, Francis E. and Shi, Dan and Sangwan, Smriti and Guenther, Elizabeth L. and Johnson, Lisa M. and Zhang, Meng and Jiang, Lin and Arbing, Mark A. and Nannenga, Brent L. and Hattne, Johan and Whitelegge, Julian and Brewster, Aaron S. and Messerschmidt, Marc and Boutet, Sébastien and Sauter, Nicholas K. and Gonen, Tamir and Eisenberg, David S.}, year={2015}, month=sep, pages={486–490} }